Vaccination with the T cell antigen Mtb 8.4 Protects against challenge with Mycobacterium tuberculosis

Journal of Immunology

Volumn 166, Issue 10, 2001, Pages 6227-6235

  Coler, Rhea N ^a   Campos Neto, Antonio ^a,b   Ovendale, Pamela ^c   Day, Fiona H ^c   Fling, Steven P ^c   Zhu, Liqing ^c   Serbina, Natalya ^d   Flynn, JoAnne L ^d   Reed, Steven G ^a,c   Alderson, Mark R ^c  

^a INFECTIOUS DISEASE RESEARCH INSTITUTE   (United States)

^b Itajuba Federal School of Engineering   (Brazil)

^c GLAXOSMITHKLINE   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; PLASMID DNA; RECOMBINANT ANTIGEN; T LYMPHOCYTE ANTIGEN; TUBERCULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BCG VACCINATION; CONTROLLED STUDY; CYTOTOXICITY TEST; FEMALE; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MOUSE; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TUBERCULIN TEST; VACCINATION;

EID: 0035873516     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.10.6227     Document Type: Article

References (54)

1. World Health Organization. 1998. Global Tuberculosis Control. World Health Organization, Geneva, Switzerland.
2. Colditz, G. A., T. F. Brewer, C. S. Berkey, M. E. Wilson, E. Burdick, H. V. Fineberg, and F. Mosteller. 1994. Efficacy of GCG vaccine in the prevention of tuberculosis: meta-analysis of the published literature. J. Am. Med. Assoc. 271:698.
3. Dolin, P. J., M. C. Raviglione, and A. Kochi, 1994. Global tuberculosis incidence and mortality during 1900-2000. Bull. W. H. O. 72:213.
4. Orme, I. M., P. Andersen, and W. H. Boom. 1993. T cell response to Mycobacterium tuberculosis. J. Infect. Dis. 167:1481.
5. Silva, C. L., M. F. Silva, R. C. Pietro, and D. B. Lowrie. 1996. Characterization of T cells that confer a high degree of protective immunity against tuberculosis in mice after vaccination with tumor cells expressing mycobacterial hsp65. Infect. Immun. 64:2400.
6. Andersen, P. 1997. Host responses and antigens involved in protective immunity to Mycobacterium tuberculosis. Scand. J. Immunol. 45:115.
7. Cooper, A. M., and J. L. Flynn. 1995. The protective immune response to Mycobacterium tuberculosis. Curr. Opin. Immunol. 7:512.
8. D'Sousa, C. D., A. M. Cooper, A. A. Frank, and I. M. Orme. 1998. The role of CD8 cells in acquired immunity and pulmonary tuberculosis in the mouse model. In TB Molecular Methods and Immunological Aspects. G. Kaplan and P. Brennan, eds. Keystone Symposia, Keystone, CO, April 2-8, 1998, p. 47.
9. Flynn, J. L., M. M. Goldstein, K. J. Triebold, B. Koller, and B. R. Bloom. 1992. Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc. Natl Acad. Sci. USA 89:12013.
10. Kaufmann, S. H. 1995. Immunity to intracellular microbial pathogens. Immunol. Today 16:338.
11. Hubbard, R. D., C. M. Flory, and F. M. Collins. 1991. Memory T cell-mediated resistance to Mycobacterium tuberculosis infection in innately susceptible and resistant mice. Infect. Immun. 59:2012.
12. + T cells. Infect. Immun. 55:2037.
13. + T cells requires the production of γ interferon. Infect. Immun. 66:830.
14. Huygen, K., J. Content, O. Denis, D. L. Montgomery, A. M. Yawman, R. R. Deck, C. M. DeWitt, I. M. Orme, S. Baldwin, C. D'Souza, et al. 1996. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nat. Med. 2:893.
15. Lowrie, D. B., C. L. Silva, M. J. Colston, S. Ragno, and R. E. Tascon. 1997. Protection against tuberculosis by a plasmid DNA vaccine. Vaccine 15:834.
16. Morris, S., C. Kelley, A. Howard, Z. Li, and F. Collins. 2000. The immunogenicily of single and combination DNA vaccines against tuberculosis. Vaccine 18:2155.
17. Tascon, R. E., M. J. Colston, S. Ragno, E. Stavropoulos, D. Gregory, and D. B. Lowrie. 1996. Vaccination against tuberculosis by DNA injection. Nat. Med. 2:888.
18. + T-cell epitopic repertoire broader than that stimulated by Mycobacterium tuberculosis H37Rv infection. Infect. Immun. 66:1527.
19. Kamath, A. T., C. G. Feng, M. Macdonald, H. Briscoe, and W. J. Britton. 1999. Differential protective efficacy of DNA vaccines expressing secreted proteins of Mycobacterium tuberculosis. Infect. Immun. 67:1702.
20. Li, Z., A. Howard, C. Kelley, G. Delogu, F. Collins, and S. Morris. 1999. Immunogenicity of DNA vaccines expressing tuberculosis proteins fused to tissue plasminogen activator signal sequences. Infect. Immun. 67:4780.
21. Morris, S., C. Kelley, A. Howard, Z. Li, and F. Collins. 2000. The immunogenicity of single and combination DNA vaccines against tuberculosis. Vaccine 18:2155.
22. Bonato, V. L., V. M. Lima, R. E. Tascon, D. B. Lowrie, and C. L. Silva. 1998. Identification and characterization of protective T cells in hsp65 DNA-vaccinated and Mycobacterium tuberculosis-infected mice. Infect. Immun. 66:169.
23. Lowrie, D. B., C. L. Silva, and R. E. Tascon. 1997. Genetic vaccination against tuberculosis, Springer Semin. Immunopathol. 19:161.
24. Andersen, P., D. Askgaard, L. Ljungqvist, J. Bennedsen, and I. Heron. 1991. Proteins released from Mycobacterium tuberculosis during growth. Infect. Immun. 59:1905.
25. Andersen, P. 1994. Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins. Infect. Immun. 62:2536.
26. Orme, I. 1994. Protective and memory immunity in mice infected with Mycobacterium tuberculosis. Immunobiology 191:503.
27. Pal, P. G., and M. A. Horwitz. 1992. Immunization with extracellular proteins of Mycobacterium tuberculosis induces cell-mediated immune responses and substantial protective immunity in a guinea pig model of pulmonary tuberculosis. Infect. Immun. 60:4781.
28. Coler, R. N., Y. A. Skeiky, T. Vedvick, T. Bement, P. Ovendale, A. Campos-Neto, M. R. Alderson, and S. G. Reed. 1998. Molecular cloning and immunologic reactivity of a novel low molecular mass antigen of Mycobacterium tuberculosis. J. Immunol. 161:2356.
29. Skeiky, Y. A., M. J. Lodes, J. A. Guderian, R. Mohamath, T. Bement, M. R. Alderson, and S. G. Reed. 1999. Cloning, expression, and immunological evaluation of two putative secreted serine protease antigens of Mycobacterium tuberculosis. Infect. Immun. 67:3998.
30. Kozak, M. 1986. Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes. Cell 44:283.
31. Pear, W. S., G. P. Nolan, M. L. Scott, and D. Baltimore. 1993. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA 90:8392.
32. Zhu, X., N. Venkataprasad, H. S. Thangaraj, M. Hill, M. Singh, J. Ivanyi, and H. M. Vordermeier. 1997. Functions and specificity of T cells following nucleic acid vaccination of mice against Mycobacterium tuberculosis infection. J. Immunol. 158:592.
33. Brandt, L., M. Elhay, I. Rosenkrands, E. B. Lindblad, and P. Andersen. 2000. ESAT-6 subunit vaccination against Mycobacterium tuberculosis. Infect. Immun. 68:791.
34. Cooper, A. M., D. K. Dalton, T. A. Stewart, J. P. Griffin, D. G. Russell, and I. M. Orme. 1993. Disseminated tuberculosis in interferon γ gene-disrupted mice. J. Exp. Med. 178:2243.
35. Flynn, J. L., J. Chan, K. J. Triebold, D. K. Dalton, T. A. Stewart, and B. R. Bloom. 1993. An essential role for interferon γ in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178:2249.
36. + T cells in mice vaccinated with DNA encoding Ag85A. Eur. J. Immunol. 30:2455.
37. Silva, C. L., and D. B. Lowrie. 2000. Identification and characterization of murine cytotoxic T cells that kill Mycobacterium tuberculosis. Infect. Immun. 68:3269.
38. Ramshaw, I. A., and A. J. Ramsay. 2000. The prime-boost strategy: exciting prospects for improved vaccination. Immunol. Today 21:163.
39. Hess, J., D. Miko, A. Catic, V. Lehmensiek, D. G. Russell, and S. H. Kaufmann. 1998. Mycobacterium bovis bacille Calmette-Guerin strains secreting listeriolysin of Listeria monocytogenes. Proc. Natl. Acad. Sci. USA 95:5299.
40. Mazzaccaro, R. J., M. Gedde, E. R. Jensen, H. M. van Santen, H. L. Ploegh, K. L. Rock, and B. R. Bloom. 1996. Major histocompatibility class I presentation of soluble antigen facilitated by Mycobacterium tuberculosis infection. Proc. Natl. Acad. Sci. U.S.A 93:11786.
41. Schirmbeck, R., W. Bohm, and J. Reimann 1994. Injection of detergent-denatured ovalbumin primes murine class I-restricted cytotoxic T cells in vivo. Eur. J. Immunol. 24:2068.
42. McDonough, K. A., Y. Kress, and B. R. Bloom. 1993. The interaction of Mycobacterium tuberculosis with macrophages: a study of phagolysosome fusion. Infect. Agents Dis. 2:232.
43. Teitelbaum, R., M. Cammer, M. L. Maitland, N. E. Freitag, J. Condeelis, and B. R. Bloom. 1999. Mycobacterial infection of macrophages results in membrane-permeable phagosomes. Proc. Natl. Acad. Sci. USA 96:15190.
44. Kovacsovics-Bankowski, M., K. Clark, B. Benacerraf, and K. L. Rock. 1993. Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages. Proc. Natl Acad. Sci. USA 90:4942.
45. Wren, B. W., R. A. Stabler, S. S. Das, P. D. Butcher, J. A. Mangan, J. D. Clarke, N. Casali, T. Parish, and N. G. Stoker. 1998. Characterization of a haemolysin from Mycobacterium tuberculosis with homology to a virulence factor of Serpulina hyodysenteriae. Microbiology 144:1205.
46. Li, Z., A. Howard, C. Kelley, G. Delogu, F. Collins, and S. Morris. 1999. Immunogenicity of DNA vaccines expressing tuberculosis proteins fused to tissue plasminogen activator signal sequences. Infect. Immun. 67:4780.
47. Horwitz, M. A., B. W. Lee, B. J. Dillon, and G. Harth. 1995. Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 92:1530.
48. Calarota, S., G. Bratt, S. Nordlund, J. Hinkula, A. C. Leandersson, E. Sandstrom, and B. Wahren. 1998. Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients. Lancet 351:1320.
49. Dillon, D. C., M. R. Alderson, C. H. Day, D. M. Lewinsohn, R. Coler, T. Bement, A. Campos-Neto, Y. A. Skeiky, I. M. Orme, A. Roberts, et al. 1999. Molecular characterization and human T-cell responses to a member of a novel Mycobacterium tuberculosis mtb39 gene family. Infect. Immun. 67:2941.
50. Roberts, A. D., M. G. Sonnenberg, D. J. Ordway, S. K. Furney, P. J. Brennan, J. T. Belisle, and I. M. Orme. 1995. Characteristics of protective immunity engendered by vaccination of mice with purified culture filtrate protein antigens of Mycobacterium tuberculosis. Immunology 85:502.
51. Young, D. B., S. H. Kaufmann, P. W. Hermans, and J. E. Thole. 1992. Mycobacterial protein antigens: a compilation. Mol. Microbiol. 6:133.
52. Orme, I. M. 1988. Characteristics and specificity of acquired immunologic memory to Mycobarterium tuberculosis infection. J. Immunol. 140:3589.
53. Orme, I. M., E. S. Miller, A. D. Roberts, S. K. Furney, J. P. Griffin, K. M. Dobos, D. Chi, B. Rivoire, and P. J. Brennan. 1992. T lymphocytes mediating protection and cellular cytolysis during the course of Mycobacterium tuberculosis infection: evidence for different kinetics and recognition of a wide spectrum of protein antigens. J. Immunol. 148:189.
54. Ottenhoff, T. H., and T. Mutis. 1995. Role of cytotoxic cells in the protective immunity against and immunopathology of intracellular infections. Eur. J. Clin. Invest 25:371.